Ray, Kathryn J.
Santee, Clark
McCauley, Kathryn
Panzer, Ariane R.
Lynch, Susan V.
Funding for this research was provided by:
Cystic Fibrosis Foundation (CA0073548, CA0073548, CA0073548, CA0073548, CA0073548)
Article History
Received: 7 September 2021
Accepted: 23 June 2022
First Online: 28 July 2022
Declarations
:
: The University Federico II, Naples, Italy, ethical committee approved the study in accordance with the Declaration of Helsinki. Additionally, the ethical committees of the Department of Paediatric Medicine, CF Center, “A. Meyer” Children’s Hospital in Florence, Italy and Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena in Milano, Italy approved the study. Enrolment was allowed only after signed written informed consent was obtained from patients and their caregivers/parents. At enrolment, each subject received an informative letter from his/her general practitioner. All enrolled patients were informed about the rationale, the type of intervention and the specific aims of the study by the doctors of the Regional CF Clinical Center. Medical doctors discussed with the patient and parents about the utility and the burden of intervention related to their participation to the study. During the assessment period patients could understand the required task and decide about their participation.
: Not applicable.
: The authors declare that they have no competing interests.